Disclaimer for the US market
The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.
Neither the Company nor its representatives is providing any medical advice, and none should be inferred, from any ideas, suggestions, testimonials or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites. If you decide to access or rely on information at linked third-party website, you do so at our own risk. Our terms and conditions, including disclaimers, are more fully set forth in our Terms of Use, Privacy Policy and Terms of Online Sales.
Here you will find information and news about the latest events. In this way, you can stay ‘a heartbeat ahead’
of developments.
Also available as RSS feed for your RSS feed reader.
You can subscribe to our newsletter here:
1st CARL. Summit – Shaping the Future of ECPR. Together. On September 15 and 16, CARL Academy welcomed over 100 European ECPR and CARL experts to the first edition of the CARL Summit in Freiburg, Germany. In many inspiring presentations and discussions, the leading key opinion leaders in the field shared their expertise, recent experiences…
Learn more >Resuscitec GmbH is now certified according to the European Medical Device Regulation (MDR). The MDR replaces the Directive 93/42/EEC concerning medical devices (MDD) since 2017 with respect to modern demands on harmonized assessments within the EU.
Learn more >“We are the team” was this year’s motto of the 54th Annual Meeting of the German Society of Internal Intensive and Emergency Medicine (DGIIN) and the Austrian Society of Internal and General Intensive and Emergency Medicine (ÖGIAIN) in Berlin.
Learn more >Florian Wahl, Chairman of the Committee for Social Affairs, Health and Integration in the State Parliament of Baden-Württemberg (BW), visited together with an SPD delegation from Freiburg and BW, visited the University Emergency Center of the Medical Center – University of Freiburg and the CARL Academy in the Güterhalle.
They were not only introduced to the Freiburg Model Project for Life Saving in a joint presentation and a realistic simulation but were also actively and successfully involved in the simulation of a rescue operation.
Learn more >Together with WEINMANN Emergency France, the CARL market launch in France was successfully launched at the Urgences congress in Paris. France is one of the leading European countries in extracorporeal resuscitation after cardiovascular arrest, both in-hospital and out-of-hospital.
Learn more >When an emergency call is received at the integrated control center in Freiburg and a cardiac arrest, a secured resuscitation or a drowning accident is reported, the CARL-Mobil is alerted directly in addition to an ambulance and an emergency medical service vehicle. The concept of parallel alerting thus saves valuable minutes and shortens the time until the arrival of the treatment team.
Learn more >Over 100 experts from the US and further different countries have discussed about the future of the cardiac arrest resuscitation in June at the Wolf Creek Conference in Ann Arbor, Michigan. A team of the Resuscitec GmbH has been on-site.
Learn more >In Europe, around 500,000 people suffer a sudden cardiac arrest every year. Outside of a hospital, only about 8% of those affected survive, and a high percentage of survivors suffer from neurological sequelae after resuscitation.
Learn more >The 11th Congress of the European Extracorporeal Life Support Organization (EuroELSO) will be held from April 26 to April 29 at the Congress Center in Lisbon.
Learn more >This February it was finally time again: After a two-year break in attendance due to the Covid pandemic, the Annual Meeting of the German Society for Thoracic Cardiac and Vascular Surgery (DGTHG) and the 54th Annual Meeting of the German Society for Pediatric Cardiology and Congenital Heart Defects (DGPK) could take place live again.
Learn more >